ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Qian Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8918-0313; OpenAlex author ID A5115593347. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 2 papers

Papers 2

USP10 deubiquitylates and stabilizes DIRAS2 to suppress the growth of pancreatic cancer cells. Co-author DOI 10.1002/mco2.751 ↗
The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. First author DOI 10.1016/j.devcel.2024.03.018 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yi Sun · 2 shared papers, 2024 · strength 0.60
- Paper USP10 deubiquitylates and stabilizes DIRAS2 to suppress the growth of pancreatic cancer cells. DOI 10.1002/mco2.751 ↗
- Paper The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. DOI 10.1016/j.devcel.2024.03.018 ↗
Yu Chang · 1 shared paper, 2024 · strength 0.24
- Paper The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. DOI 10.1016/j.devcel.2024.03.018 ↗
Hua Li · 1 shared paper, 2024 · strength 0.24
- Paper The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. DOI 10.1016/j.devcel.2024.03.018 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.